Report ID : 10060035 |
Published Date : 21 Oct 2022 |
Report Format : PDF,PPT |
Delivery Timeline :48-72 Business Hours
The global protein label market is projected to be valued at USD 2 billion in 2020 and is projected to grow at a CAGR of 8% from 2022 to 2030. Rising Research Costs and Development In protein research, protein analysis meets demand. Protein labeling technology. This increase in R&D costs benefits proteomics by expanding its applications in mass spectrometry, protein arrays, and biochemistry. In addition, improved mass spectrometry and biocype extraction have led to the development of protein programs and increased organic sales in the market.
As research and development costs increase, the protein content of large-scale proteomics and genomics studies accelerates the search for new biological signals. The increasing number of drugs in the R&D pipeline also complements the use of proteomics studies. The number of drugs in the R&D pipeline in 2019 was about 16,181, an increase of about 2.7% compared to 2018.
Expanding our knowledge of cellular-level functional mechanisms in pathological and physiological conditions using state-of-the-art molecular biology and biotechnology tools enhances drug development and therapeutic applications. The use of biotechnology tools has greatly increased the identification and purification of proteins based on the presence of specific proteins and the use of markers in diagnostic tests.
The use of unconventional amino acids (NCAAs) after combining proteins, polymers, synthetic reagents, peptides, or fluorine-labeled nanoparticles has been demonstrated in proteomics and biotechnology applications. These proteins are called NCAAs in cells and tissues. These new biotechnology tools will provide impetus for the temporal and spatiotemporal analysis of new dynamics of proteins and chemical processes.
The use of unconventional amino acids (NCAAs) after combining proteins, polymers, synthetic reagents, peptides, or fluorine-labeled nanoparticles has been demonstrated in proteomics and biotechnology applications. These proteins are called NCAAs in cells and tissues. These new biotechnology tools will provide impetus for the temporal and spatiotemporal analysis of new dynamics of proteins and chemical processes.
Advances in mass spectrometry to identify biomarkers and quantify disease diagnosis are expected to provide lucrative opportunities for market growth. These advances include surface-enhanced laser adsorption/ionization technology. This is an alternative version of the matrix-assisted laser/ionization process that immobilizes the method to a surface prior to large-scale analysis. It can be used to monitor the progression of colon cancer.
PRODUCT DESCRIPTION:
Reagents dominated the protein label market with a 60% sales share in 2020. The discovery of numerous genetically modified labels and tags is due to the estimated transfection rate. In addition, the commercial use of effective reagents, such as unstained protein labeling reagents that enable accurate and accurate visualization and standardization of proteins, will have a positive impact on the growth of the industry.
Rather, probes/markers are expected to witness the fastest growth during the forecast period. Several markers have been developed to characterize membrane peptide molecules for ultra-high-resolution microscopy. Moreover, the development of peptide-based affinity reagents is one of the strategies of various reagent manufacturers to achieve high labeling properties and is expected to lead to the production of more probes or labels in the near future.
PRACTICAL NOTE :
The Security Technologies segment dominates the protein labeling market with the largest share of revenue in 2020, with 40%. These techniques are mainly used in cancer research, autoimmune disease research. and tag-based therapy.
In addition, these techniques are widely used in the diagnosis of diabetes, systemic lupus erythematosus, rheumatoid arthritis, lung disease, nervous system disorders and gastrointestinal disorders. Extensive application of immunological techniques has helped to increase market share in this segment. Immunoelectron microscopy is also used to look for antigens with a resolution of 10 nm or better and estimate sales.
The rapid development of high-performance microscopy for accurate biological analysis of cellular pathways in academic research has led to a rapid development in the field of fluorescence microscopy during the analysis period. This method is more cost-effective than conventional microscopy because it analyzes large numbers of samples at high acquisition rates and allows for a neutral image acquisition method.
METHOD OVERVIEW:
From a revenue perspective, laboratory methods are expected to achieve the largest revenue growth of 70% in 2020 and record profitable growth in the near future. In these methods, some enzyme-labeled fragments dominate due to the very specific function of the enzyme. The site-specific covalent association of enzymes helps to integrate orthogonal biological functions into proteins, allowing for site-specific labeling and manipulation of proteins.
Experimental methods based on nanoparticles are expected to record the fastest CAGR from 2020 to 2027. Because of their small size, nanoparticles can reach complex sites and form covalent bonds with target proteins or peptides for better labeling and stability.
REGIONAL OVERVIEW:
North America led the protein label market with a 48% share in 2020. Research activities such as immunofluorescence techniques, fluorescence microscopy, western blotting, ELISA, and cell experiments have increased significantly in this field, and revenues that are highly dependent on the labeling method of proteins in clinical studies are generating revenue in this field.
For example, a study published in August 2019 by researchers at the U.S. National Institutes of Health showed the use of an arsenic test strip system capable of detecting fluorescent proteins at various cellular locations. This technique has paved the way for the study of the morphology and epidemiology of Borrelia and leptospirosis species that cause borreliosis and leptospirosis, respectively.
The protein label market in Asia Pacific is expected to witness profitable growth during the forecast period. This is due to ongoing research projects encouraging proteomics research in this field. The Structural Proteomics Project, Protein Expression Database, Japanese Proteomics Genomics Database, Cancer Chemotherapy and Proteomics Project are some of the ongoing projects at Structural Genomics Japan.
LARGE ENTERPRISE OVERVIEW AND MARKET SHARE:
Over the years the Protein Labeling market has grown and many markets have grown. For example, in April 2019, Perkin Elmer completed the acquisition of Cisbio Bioassays to expand its DELFIA, Alpha, and LANC testing technologies. This achievement adds to PerkinElmers Sysbio capabilities and gives researchers access to a wide range of tools for small molecule screening and biopharmaceutical discovery. Some of the most prominent players in the Protein Labeling market are: ThermoFisher Scientific, Inc. Merck KGaperkin Elmer, Inc. Promega Corporation F. Hoffman-La Method Ltd. LGC Ltd., New England, Biolabs LI-COR, Inc. GE Healthcare Jena Bioscience GmbH.
SCIENCE INCLUDED IN THE REPORT:
The report forecasts global, regional and national sales growth and provides an analysis of the latest industry trends for each subsector from 2021-2030. In this study, the Global Protein Labeling Market Reports According to the Kenneth Research report of: Product Base, Methods, Applications and Regions: Product Forecast (Sales, USD 1 million, 2021-2030) Reagent Protein Enzyme Reason/Label Monomer Antibody Other Services Expression Services Outlook Services (Sales, 1 Million Dollar, 2021-2030) Immunofluorescence Protein Microarray Assay-Based Cell Microfluorescence Measurement Method (Revenue, Million Dollar, 2021-2030) Laboratory Labeling Enzyme Labeling Color Label Translation Active Site Label Translation.
